End-to-end cell therapy development and manufacturing
Our teams of scientists have 30 years of cell therapy development, manufacturing and regulatory experience, including bringing three commercial products to market.
We offer industry-leading expertise in PD and internalizing client cell therapy processes, including customization, development, qualification and validation activities for manufacturing and analytics.
AGC Biologics’ services support every stage of the product journey, from pre-clinical through commercialization.Have a project in mind?
Cell and gene therapy treated patients
Commercial cell therapies
Cell and gene therapy trials supplied in EU and US
Autologous & allogeneic methods and processes
Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. We also have flexible and cost-effective services for process development and pre-clinical needs.
Our teams of experts at two global sites bring the quality systems background and regulatory experience to help you navigate the important cell therapy product milestones, at any stage of the journey.
Industry analysis: creating cost-effective cell therapy programs with NK Cells
As this cell type continues to grow in popularity there are several strategies to consider for building a treatment program.Download
Fill out the form to access "The promise of NK cells and 3 strategies for creating a cost-effective program"
We work with virtually any cell type, including Hematopoietic stem cells (HSCs), Human Mesenchymal Stem Cells (hMSCs), T Cells, NK Cells, and more.
95% of analytical tests performed in-house, reducing overall turnaround time and shortening your project timeline.
Best-in-class cell therapy CDMO services:
Full life cycle stage support, from development up to clinical and commercial manufacturing
Cell culture and modification in PD and cGMP environments
Development of small, medium, and large-scale engineered cells, analytical method development and qualification
Extensive experience with receiving and working on fresh and frozen starting material
Strategic development partnership with hMSCs and Exosome cell manufacturing platform technology company RoosterBio to provide the best cell media possible
Proven expertise in Lenti and Retro viral transduction for cell engineering
Manufacturing suites of different sizes and equipment with open and closed processes for autologous and allogeneic manufacturing
- Broad experience with diverse types of client processes based both on 2D and 3D cell culture protocols
Cells filled in vials and bags using a manual or semi-automated process, offering automated fill and finish
160+ in-house analytical tests with custom designs for clinical and commercial supply
Globally aligned quality systems and an innate understanding of cell and gene regulatory and inspection processes